• (+381 11) 3088 132
  • info@amcham.rs
Linkedin Twitter Instagram Facebook Youtube
Join us!
  • About Us
    • Board of Governors
    • Executive Team
  • Members
    • Patron members
    • Join Us
  • Improving Business Environment
    • Business and Corporate Law Committee
    • Combating Grey Economy Committee
    • Digital Economy Committee
    • Environmental Committee
    • Energy Committee
    • Health Care Committee
    • Labor Regulations Committee
    • Real Estate Committee
    • Tax and Finance Committee
    • Trade Facilitation Committee
  • Networking & Promotion
  • Excelling Professional Development
    • AmChamps
    • Women in Tech
    • HR Forum
  • News & Galleries
    • News
    • Image Gallery
    • Video Gallery
  • Calendar
  • Resources
    • Annual Reports
    • Lap Time Surveys
    • Other Important Documents
  • Contact Us
  • English
Menu
  • About Us
    • Board of Governors
    • Executive Team
  • Members
    • Patron members
    • Join Us
  • Improving Business Environment
    • Business and Corporate Law Committee
    • Combating Grey Economy Committee
    • Digital Economy Committee
    • Environmental Committee
    • Energy Committee
    • Health Care Committee
    • Labor Regulations Committee
    • Real Estate Committee
    • Tax and Finance Committee
    • Trade Facilitation Committee
  • Networking & Promotion
  • Excelling Professional Development
    • AmChamps
    • Women in Tech
    • HR Forum
  • News & Galleries
    • News
    • Image Gallery
    • Video Gallery
  • Calendar
  • Resources
    • Annual Reports
    • Lap Time Surveys
    • Other Important Documents
  • Contact Us
  • English
Members News

Hemofarm marks 61st anniversary

By AmCham  Published On 01/06/2021
Since 2006, Hemofarm has been part of Stada Group, a leading European pharmaceuticals company, which has invested some 300 million euros in modernising the company’s plants, equipment, and facilities.
Dr Ronald Zeliger, General Manager of Hemofarm, said the company’s growth was due to its business model, which prioritised continuous investment: ‘Hemofarm is great because it produces medicines for the whole world, but it grew exactly owing to regular investments, constant innovations in production and continuous investment in people and processes. The fact that we are a part of One Stada, which strongly enters the field of innovation in all segments of pharmaceutical development, is the reason for our success. In return, we hold a leading market position, achieve a record-breaking production in accordance with sustainable development principles, and provide maximum quantities of high-quality medicines available in pharmacies on three continents.’
This year’s plan is to invest some 28 million euros in Hemofarm’s operations in Serbia, close to 10 million euros in Bosnia and Herzegovina, and 1.5 million euros in Montenegro.

Leave A Reply Cancel reply

Your email address will not be published. Required fields are marked *

*

*

3 × 4 =

AmCham holds #IamRemarkable Workshop in collaboration with Google
Previous Article
Final event held for AmChamps – Young Leaders in Change 2020
Next Article

AmCham Serbia

The leading independent  business association in Serbia

Twitter Linkedin Instagram Facebook Youtube

Explore

ABOUT US
MEMBERS
NEWS & GALLERIES
CALENDAR
RESOURCES
IMPROVING BUSINESS ENVIRONMENT
NETWORKING & PROMOTION
EXCELLING PROFESSIONAL DEVELOPMENT

Address

info@amcham.rs

Smiljanićeva 24/I, 11000 Beograd

Copyright 2022. Made with ❤ by CodeIT

AmCham Serbia

The leading independent  business association in Serbia

Twitter Linkedin Instagram Facebook Youtube

Explore

ABOUT US
MEMBERS
NEWS & GALLERIES
CALENDAR
RESOURCES
IMPROVING BUSINESS ENVIRONMENT
NETWORKING & PROMOTION
EXCELLING PROFESSIONAL DEVELOPMENT

Address

info@amcham.rs

Smiljanićeva 24/I, 11000 Beograd

Copyright 2022. Made with ❤ by CodeIT